Company Executing Strategic Transformation to Become Diversified Land Company; Concludes the Majority of its Capital Investment on Citrus Operations After Completion of the Fiscal Year 2025 Harvest in April 2025 Company Raises Land Sales Outlook to Potentially Exceed $50 million for Fiscal Year 2025 Expanded Financial Guidance Now Includes Cash Balance, Net Debt and Adjusted EBITDA Targets for Fiscal Year 2025 Robust Liquidity Position with $14.7 million in Cash and Cash Equivalents, $88.5 million in Availa ...

Core Viewpoint - Wesdome Gold Mines Ltd. reported strong financial results for Q1 2025, achieving record revenue, net income, and free cash flow, driven by higher gold prices and operational efficiencies [3][7]. Financial Highlights - Revenue for Q1 2025 was CAD 187.6 million, an 86% increase from CAD 100.9 million in Q1 2024 [8]. - Gross profit surged by 365% year-over-year to CAD 103.4 million, with a cash margin growth of 174% to CAD 127.6 million [7][8]. - Net income reached CAD 62.5 million, or CAD 0.42 per share, marking a nearly fivefold increase from CAD 10.7 million in Q1 2024 [7][8]. - EBITDA increased by 193% to CAD 119.4 million, primarily due to higher ounces sold and a higher average realized price of gold [7][8]. - Free cash flow was CAD 47.5 million, a 144% increase from CAD 19.4 million in Q1 2024 [7][8]. Operational Highlights - Consolidated gold production was 45,692 ounces, a 37% increase compared to Q1 2024 [7][8]. - Cost of sales per ounce sold decreased by 18% to USD 923, while all-in sustaining costs (AISC) per ounce sold declined 17% to USD 1,366 [7][8]. - The average realized price of gold sold in Q1 2025 was USD 2,882 per ounce, reflecting a 38% increase from the previous year [7][8]. Eagle River Mine Performance - Eagle River produced 28,999 ounces of gold in Q1 2025, a 16% increase from 24,899 ounces in Q1 2024, benefiting from high-grade material from the 300 Zone [12][14]. - Revenue from Eagle River increased by 49% to CAD 115.5 million due to a higher average realized price of gold [14][15]. - Cash costs per ounce sold were CAD 1,327 (USD 925), an 8% increase from the previous year [15][16]. Kiena Mine Performance - Kiena produced 16,693 ounces of gold in Q1 2025, a 98% increase from 8,423 ounces in Q1 2024, attributed to high-grade ore from Kiena Deep [24][27]. - Revenue at Kiena increased by 209% to CAD 71.9 million, driven by a 111% increase in ounces sold [27][28]. - AISC per ounce of gold sold decreased by 50% to CAD 2,026 (USD 1,412) compared to CAD 4,078 (USD 3,023) in Q1 2024 [28]. Exploration and Growth Strategy - The company continues to focus on exploration to extend mine life and identify new growth opportunities [6]. - Drilling in the 6 Central Zone and the 300 Zone is ongoing, with promising results indicating potential for further discoveries [17][19]. - The acquisition of Angus Gold is expected to enhance the company's land package and exploration potential [7].

If you use Airbnbs to avoid booking a cramped hotel space, you've been missing out on the associated amenities that are fundamental to a good vacation. But even if you don't get any room service, the new Airbnb Services feature strives to help you find other ways to relax -- allowing you to book spas, massages and more near where you're staying.Airbnb Services is designed to help you book services you would get at a more traditional hotel. The initial rollout of the feature includes 10 distinct categories i ...

Core Viewpoint - Constellation Brands is expected to grow faster than the beer industry despite a current slowdown, primarily due to its strong brand portfolio, particularly Modelo Especial [2]. Company Outlook - The company recently revised its growth outlook for the beer business, attributing the changes to non-structural factors related to macroeconomic conditions and Hispanic consumer behavior [3]. - Confidence in the brand's health and the ability to manage controllable factors supports the belief that the slowdown is transitory rather than structural [4].

Core Insights - Atrium Mortgage Investment Corporation reported strong first quarter results, with earnings per share exceeding dividends and a significant increase in new loan origination despite a challenging market [3][4] - The company has successfully reduced its loan-to-value ratio and increased the percentage of conventional mortgages, contributing to a resilient portfolio [4][6] Financial Performance - For Q1 2025, Atrium reported total assets of $852.8 million, a decrease from $864.3 million at the end of 2024 [6] - Net income for the first quarter was $11.9 million, down 1.2% from the same period last year [6] - Basic and diluted earnings per share were $0.25, a decrease of 7.4% compared to $0.27 in the prior year [7][10] - The mortgage portfolio stood at $875.0 million, with mortgages receivable at $851.6 million, down from $863.2 million at the end of 2024 [8][10] Portfolio Quality - The loan-to-value ratio improved from 64.0% to 61.1% over the past year, with 96.3% of the portfolio being conventional mortgages [4][10] - Stage 3 loans decreased to 2.2% of the mortgage portfolio, the lowest since Q2 2023 [4] - The weighted average interest rate on the mortgage portfolio was 9.56%, down from 9.98% at the end of 2024 [8][10] Mortgage Portfolio Breakdown - As of March 31, 2025, the mortgage portfolio comprised 75.9% residential and 24.1% commercial properties [12] - The majority of the portfolio (88.8%) is located in the Greater Toronto Area, with a weighted average loan-to-value of 60.3% [14]

Core Viewpoint - American Eagle is facing significant challenges, including a $75 million write-off of spring and summer merchandise, slow sales, and has withdrawn its full-year guidance due to an uncertain economic environment [1][6]. Financial Performance - The company expects first-quarter revenue to be approximately $1.1 billion, reflecting a decline of about 5% year-over-year [2]. - Comparable sales are anticipated to drop by 3%, with a notable 4% decline expected in the intimates brand Aerie [2]. - An operating loss of around $85 million is projected, with an adjusted operating loss of about $68 million for the quarter, attributed to higher-than-planned discounting and the $75 million inventory charge [4]. Management Commentary - CEO Jay Schottenstein expressed disappointment with the company's execution in the first quarter, citing ineffective merchandising strategies that led to increased promotions and excess inventory [5]. - The company has entered the second quarter with inventory better aligned to sales trends and is actively evaluating forward plans to strengthen product performance [6]. Market Conditions - The company has withdrawn its fiscal 2025 guidance due to macroeconomic uncertainty and is reviewing its forward plans in light of first-quarter results [6]. - There is uncertainty regarding the impact of recent tariff policy changes on American Eagle's operations [6].

Company Overview - Petrobras held its Q1 2025 Earnings Conference Call on May 13, 2025, featuring key executives including CEO Magda Chambriard and CFO Fernando Melgarejo [1][3]. Participants - The conference call included participants from major financial institutions such as Goldman Sachs, Bank of America, JPMorgan, and Morgan Stanley, among others [2]. Executive Team - The executive team present during the call included various directors responsible for different sectors such as Exploration and Production, Logistics, and Energy Transition [3].

Core Viewpoint - A lawsuit has been filed against Elevance Health, Inc. and certain senior executives for potential violations of federal securities laws, specifically related to misleading statements about Medicaid cost trends and financial guidance [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Indiana, captioned Miller v. Elevance Health, Inc., et al., No. 25-cv-0092 [2]. - Investors have until July 11, 2025, to request to be appointed to lead the case [2]. Group 2: Company Operations and Allegations - Elevance provides health insurance plans, including Medicaid benefits, and was under scrutiny for its handling of Medicaid eligibility redeterminations that resumed in 2023 after a pause during COVID [3]. - The company claimed to be monitoring cost trends related to the redetermination process and believed its negotiated rates were adequate for the risk profiles of Medicaid patients [4]. Group 3: Financial Impact and Stock Performance - Allegations suggest that the redetermination process led to a significant increase in the acuity and utilization of Elevance's Medicaid members, which was not reflected in the company's financial guidance for 2024 [5]. - Following a statement on July 17, 2024, regarding increased Medicaid utilization, Elevance's stock price fell by $32.21, nearly 6%, from $553.14 to $520.93 per share [6]. - On October 17, 2024, Elevance reported Q3 2024 results, missing consensus EPS expectations by $1.33, or 13.7%, due to elevated medical costs in its Medicaid business, resulting in a stock price decline of $52.61, nearly 11%, from $496.96 to $444.35 per share [7].

Core Insights - Azitra, Inc. is focused on developing innovative therapies for precision dermatology, with key programs targeting major dermatological diseases [3][5] - The company reported a net loss of $3.1 million for Q1 2025, compared to a loss of $2.9 million in Q1 2024, indicating ongoing financial challenges [7][12] - Azitra has received Fast Track designation from the FDA for its ATR-04 program, which addresses EGFRi-associated rash affecting approximately 150,000 patients annually in the U.S. [3][5] Business Highlights - The CEO highlighted the importance of 2025 for Azitra, with initial safety data for ATR-12 expected in the first half of the year and topline results by year-end [3] - The company plans to dose the first patient in the Phase 1/2 trial for ATR-04 by mid-2025, with a presentation scheduled at the prestigious ASCO 2025 conference [3][6] - Azitra's proprietary platform includes a microbial library of approximately 1,500 bacterial strains, enhanced by AI and machine learning for drug development [8] Financial Results - R&D expenses for Q1 2025 were $1.3 million, down from $1.5 million in Q1 2024, while G&A expenses increased to $1.9 million from $1.5 million [7][12] - As of March 31, 2025, the company had cash and cash equivalents of $3.2 million, a decrease from $4.6 million at the end of 2024 [7][12] - Total operating expenses for Q1 2025 were $3.1 million, compared to $3.0 million in the same period of 2024 [12]

Core Points - Total Energy Services Inc. held its annual meeting of shareholders on May 13, 2025, with 25,209,233 common shares represented, accounting for 66.3% of the issued and outstanding shares [1] Voting Outcomes - The election of directors was successful for all nominees: - George Chow received 23,566,942 votes (99.6% for) [2] - Glenn Dagenais received 23,434,702 votes (99.1% for) [2] - Daniel Halyk received 23,619,795 votes (99.8% for) [2] - Jessica Kirstine received 23,436,823 votes (99.1% for) [2] - Tim McMillan received 23,605,915 votes (99.8% for) [2] - Ken Mullen received 20,601,943 votes (87.1% for) [2] - The appointment of MNP LLP as auditors was also approved with 25,144,350 votes (99.7% for) [2] Company Overview - Total Energy provides various services including contract drilling, equipment rentals, transportation services, well servicing, and compression and process equipment to the energy and resource industries, operating in North America and Australia [2]